European Journal of Gynaecological Oncology. 2026; 47(2): 60-60. doi: 10.22514/ejgo.2026.020
Retraction

Retraction: Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors

European Journal of Gynaecological Oncology Editorial Office1,*,

1MRE Press No. 50 Tagore Lane, 03-01 (H), 787494 Singapore, Singapore

*Corresponding Author(s):editor@ejgo.net (European Journal of Gynaecological Oncology Editorial Office)

History Published: 15 April 2026
Copyright:  ©2026 The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

No abstract available.

Keywords:None.
PDF(217.47 kB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

European Journal of Gynaecological Oncology Editorial Office. Retraction: Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors. European Journal of Gynaecological Oncology. 2026; 47(2): 60-60. doi: 10.22514/ejgo.2026.020

Post-publication, an investigation initiated by editorial team identified that a large proportion of the references cited in the article [1] have low relevance or no direct connection to the study’s methods, results, or discussion. This extensive use of irrelevant citations undermines the academic rigor and reliability of the published work. The article is therefore retracted. The authors did not respond with the retraction.

The journal apologizes to its readers for any inconvenience caused.

References

Liu XX, Han Y. Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors. European Journal of Gynaecological Oncology. 2025; 46: 130–137.

[Google Scholar]